 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
 |
|||||||
|
||||||||||||||||||||||||
|
Archive Question and Answer Session
based on Real World Best Practices for DVT Prophylaxis As a follow-up to the live or web program, the faculty led a live web and teleconference Q&A session.Click on the link below to listen to these archive Q&A sessionsDisclaimer©2006 Scinexa, LLC / CMEdiscovery.com. All rights reserved. None of the contents may be reproduced in any form without prior written permission from Scinexa, LLC. The views and opinions expressed in this activity are those of the faculty. They do not reflect the views of Sanofi-Aventis, any other manufacturer of pharmaceuticals, ArcMesa Educators, or Scinexa, LLC. The recommendations made in this program are based upon a combination of randomized clinical trials, current guidelines, and the clinical practice experience of the participating panelists. Any medications, diagnostic procedures or treatments discussed by the panelists should not be utilized without evaluation of their patient's conditions. Participants are urged to consult the full prescribing information on any drug mentioned in this activity for recommended dosage, indications, contraindications, warnings, precautions, and adverse effects before prescribing any medication.
|
Listen to our distinguished faculty as they answer questions and provide concise and contemporary insight into the real world concerns of practitioners with regard to the management of patients with venous thromboembolism.
Faculty
|
